SOLV vs CRL — Key Metrics
| Metric | SOLV (SOLVENTUM CORP) | CRL (CHARLES RIVER LABORATORIES INTERNATIONAL INC) |
|---|---|---|
| Price | 88.15 | 295.01 |
| Market Cap | 15.01 Billion | 14.08 Billion |
| P/E (TTM) | 10.72 | -61.59 |
| P/B (Quarterly) | 3.102 | 4.383 |
| P/S (TTM) | 1.81 | 3.52 |
| Net Profit Margin (TTM) | 17.3 | -6.0 |
| Gross Margin (TTM) | 54.7 | 32.7 |
| ROE (TTM) | 29.0 | -7.7 |
| Revenue Growth YoY (TTM) | None | None |
Upfront Investment - S&P 500 Stock Comparison & AI Analysis
AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.
Performance Comparison
AI Model Recommendation
SOLV · SOLVENTUM CORP
Outperform
CRL · CHARLES RIVER LABORATORIES INTERNATIONAL INC
Greatly Underperform
Recommendation Summary
Stock SOLV is projected to outperform the market, stock CRL is projected to greatly underperform the market. Upfront Recommendation: SOLV.
Financial Metrics
Prices delayed ~15 min
| SOLV | Metrics | CRL |
|---|---|---|
| $88.15 | Price | $295.01 |
| — | Market Capitalization | — |
| 1.81 | Price to Sales | 3.52 |
| 3.3 | Price to Gross Profit | 10.78 |
| 4.01 | Price to Current Assets | 9.21 |